BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2011
View Archived Issues
Novartis claims novel agents for treatment of cancer
Read More
Phase IIb immunological data disclosed on Bionor Pharma's therapeutic HIV vaccine
Read More
Novel GSK-3 inhibitor improves behavioral dysfunction in murine model of Alzheimer's disease
Read More
New cyclin-dependent kinase 9 inhibitors presented by Vichem Chemie Kutato
Read More
Kowa claims new angiotensin AT receptor antagonists/PPAR-gamma agonists
Read More
Array BioPharma patents new CSF-1-R inhibitors
Read More
GSK prepares novel antagonists of amiloride-sensitive sodium channel
Read More
Ebiotec vaccine suppresses Alzheimer's disease symptoms in vivo
Read More
Abbott updates progress of second quarter 2011
Read More
Orally active histone deacetylase inhibitor displays potent antitumor activity in vivo
Read More
Bionovo completes animal toxicology studies of Menerba
Read More
Phase II trial of PC-SOD planned in Japan and Korea
Read More
Promising new approach to treat Alzheimer's disease targets pTau
Read More
European Commission grants conditional approval to Fampyra
Read More
NanoViricides' lead anti-HIV candidate protects human CD4+ CD8+ T cells
Read More
Johnson & Johnson profiles highlights of second quarter 2011
Read More
FDA approves clinical trial of gene therapy for Wiskott-Aldrich syndrome
Read More
Vical-Astellas licensing agreements effective for TransVax
Read More
Raptor Pharmaceuticals reports phase III results on RP-103
Read More
Rib-X receives first milestone payment under Sanofi antibiotics collaboration
Read More
EMA recommends orphan drug status for 4SC's resminostat
Read More
Takeda resubmits NDAs for two diabetes therapies
Read More
Kyowa Hakko Kirin seeks Japanese approval for KW-6500
Read More
CHMP recommends new label update for GSK's Pandemrix
Read More
FDA approves new route of administration for Gammagard Liquid
Read More